Oak Grove Capital LLC raised its stake in Danaher Co. (NYSE:DHR – Get Rating) by 64.8% during the first quarter, HoldingsChannel reports. The institutional investor owned 32,615 shares of the conglomerate’s stock after acquiring an additional 12,826 shares during the period. Danaher comprises about 1.9% of Oak Grove Capital LLC’s investment portfolio, making the stock its 16th largest position. Oak Grove Capital LLC’s holdings in Danaher were worth $9,567,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds also recently made changes to their positions in the stock. AGF Investments LLC grew its holdings in Danaher by 2.5% during the 1st quarter. AGF Investments LLC now owns 2,310 shares of the conglomerate’s stock worth $678,000 after acquiring an additional 57 shares during the period. AGF Investments America Inc. grew its stake in Danaher by 0.7% during the first quarter. AGF Investments America Inc. now owns 95,401 shares of the conglomerate’s stock worth $27,984,000 after purchasing an additional 648 shares during the period. San Luis Wealth Advisors LLC bought a new stake in Danaher in the first quarter worth approximately $1,243,000. WD Rutherford LLC lifted its stake in Danaher by 1.2% in the first quarter. WD Rutherford LLC now owns 4,252 shares of the conglomerate’s stock valued at $1,247,000 after buying an additional 50 shares during the period. Finally, Core Alternative Capital boosted its holdings in shares of Danaher by 257.0% during the 1st quarter. Core Alternative Capital now owns 2,581 shares of the conglomerate’s stock worth $757,000 after buying an additional 1,858 shares in the last quarter. Institutional investors and hedge funds own 78.42% of the company’s stock.
Danaher Stock Down 1.3 %
Shares of NYSE DHR traded down $3.95 during trading on Wednesday, hitting $296.53. The stock had a trading volume of 43,321 shares, compared to its average volume of 2,118,268. The firm has a fifty day moving average of $265.83 and a two-hundred day moving average of $269.07. The company has a market capitalization of $215.71 billion, a PE ratio of 35.02, a PEG ratio of 2.42 and a beta of 0.86. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.75 and a quick ratio of 1.32. Danaher Co. has a 12 month low of $233.71 and a 12 month high of $333.96.
Analysts Set New Price Targets
A number of research analysts recently issued reports on the stock. UBS Group boosted their target price on shares of Danaher from $297.00 to $323.00 and gave the company a “buy” rating in a research report on Thursday, July 28th. StockNews.com upgraded Danaher from a “buy” rating to a “strong-buy” rating in a research note on Saturday, July 30th. Barclays upped their price target on Danaher from $290.00 to $310.00 in a research note on Friday, July 22nd. Robert W. Baird raised their price objective on Danaher from $319.00 to $325.00 in a research note on Friday, July 22nd. Finally, Evercore ISI lowered their target price on Danaher from $320.00 to $280.00 and set an “outperform” rating on the stock in a research report on Tuesday, July 5th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $326.50.
In related news, Director Walter G. Lohr sold 3,906 shares of Danaher stock in a transaction on Friday, July 22nd. The stock was sold at an average price of $273.84, for a total transaction of $1,069,619.04. Following the sale, the director now directly owns 12,115 shares in the company, valued at $3,317,571.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Danaher news, Director Walter G. Lohr sold 3,906 shares of the business’s stock in a transaction dated Friday, July 22nd. The shares were sold at an average price of $273.84, for a total value of $1,069,619.04. Following the transaction, the director now directly owns 12,115 shares in the company, valued at $3,317,571.60. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Joakim Weidemanis sold 12,000 shares of the stock in a transaction that occurred on Monday, July 25th. The shares were sold at an average price of $271.13, for a total transaction of $3,253,560.00. Following the transaction, the executive vice president now directly owns 74,398 shares of the company’s stock, valued at $20,171,529.74. The disclosure for this sale can be found here. 11.20% of the stock is currently owned by corporate insiders.
Danaher Company Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy.
- Get a free copy of the StockNews.com research report on Danaher (DHR)
- Lowe’s Stands Out Amid Q2 Retail Reports
- Agilent Technologies Proves Its Worth VS Illumina
- Target’s Results Cap Upside Potential For Retail Stocks
- Are These 3 Video Game Stocks Now In Play?
- 2 Long-Term EV Plays Trading Under $20
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.